VistaGen Therapeutics Inc. (NASDAQ: VTGN)
$3.89
+0.0500 ( +1.30% ) 94.2K
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Market Data
Open
$3.89
Previous close
$3.84
Volume
94.2K
Market cap
$105.67M
Day range
$3.72 - $3.96
52 week range
$1.63 - $24.71
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 26, 2024 |
| 10-k | Annual reports | 82 | Jun 11, 2024 |
| 8-k | 8K-related | 15 | Jun 11, 2024 |
| 8-k | 8K-related | 14 | May 31, 2024 |
| 8-k | 8K-related | 16 | May 24, 2024 |
| 8-k | 8K-related | 17 | Apr 26, 2024 |
| def | Proxies and info statements | 6 | Apr 16, 2024 |
| pre | Proxies and info statements | 4 | Apr 05, 2024 |
| 8-k | 8K-related | 15 | Apr 01, 2024 |
| 4 | Insider transactions | 2 | Mar 06, 2024 |